Kaylin Klie, MD, MA

Professional Titles

• Addiction Medicine Fellowship Program Director

Publications

• Johnson A, Swenson KS, Dillner E, Klie KA, Duncan R, Brandspigel S, Breen K. Addressing Perinatal Substance Use: A Triad Approach Led by the Colorado Perinatal Care Quality Collaborative. J Midwifery Womens Health. 2024 Jul-Aug;69(4):586-592. PubMed PMID: 38339840
• Klie KA, Nagle-Yang S, Zhao L, Fringuello ME. Integrated Care for Pregnant and Parenting People With Substance Use. Clin Obstet Gynecol. 2024 Mar 1;67(1):200-221. PubMed PMID: 38095083
• Johnson A, Swenson KS, Dillner E, Klie KA, Duncan R, Brandspigel S, Breen K. Addressing Perinatal Substance Use: A Triad Approach Led by the Colorado Perinatal Care Quality Collaborative. J Midwifery Womens Health. 2024 Feb 9. [Epub ahead of print] PubMed PMID: 38339840
• Klie KA, Nagle-Yang S, Zhao L, Fringuello ME. Integrated Care for Pregnant and Parenting People with Substance Use. Clin Obstet Gynecol. 2023 Dec 14. [Epub ahead of print] PubMed PMID: 38095083
• Wethern, T, Klie, KA (2023) ACAAM Self-Assessment Module 215. A Review of the Metabolism and Potential Drug-Drug Interactions with Addiction Drugs. ACAAM Addiction Medicine Portal, http://addictionme.org/.
• Kulick, B, Klie, KA (2023) ACAAM Self-Assessment Module 188. Prescribing Characteristics Associated with Opioid Overdose Following Buprenorphine Taper. ACAAM Addiction Medicine Portal, http://addictionme.org/.
• Wethern, T, Klie, K, Calcaterra, S, Thurstone, C. “Fentanyl to Buprenorphine Extended Release in two Adolescents without Sublingual Buprenorphine Stabilization”. American Society of Addiction Medicine, Washington, DC. April 2023
• Stewart, S, Klie, KA Protecting Good Samaritans Bearing Naloxone. Colorado Politics. May 9th, 2023. https://www.coloradopolitics.com/opinion/protecting-good-samaritans-bearing-naloxone-opinion/article_f06e2858-ee10-11ed-80a5-5f8f95c3375c.html
• Calcaterra SL, Klie KA. Methadone, Buprenorphine, or Detoxification for Management of Perinatal Opioid Use Disorder: A Cost-Effectiveness Analysis. Obstet Gynecol. 2020 Apr;135(4):975. PubMed PMID: 32217961
• Terasaki D, Klie K. Tramadol Withdrawal in the Setting of Buprenorphine Induction: A Case Report. J Addict Med. 2020 May Jun;14(3):264-266. PubMed PMID: 31574012
• Klie, K. Pharmacologic treatment of opioid use disorders in pregnancy. Seminars in Perinatology. In press.
• Terasaki D, Klie K. Tramadol Withdrawal in the Setting of Buprenorphine Induction: A Case Report. J Addict Med. 2019 Sep 30. [Epub ahead of print] PubMed PMID: 31574012
• Rodriguez CE, Klie KA. Pharmacological treatment of opioid use disorder in pregnancy. Semin Perinatol. 2019 Apr;43(3):141-148. PubMed PMID: 30755340
• Klie, K. (2018). Medical Comorbidities in Women with Opioid Use Disorders in Pregnancy. In T. Wright (Ed.), Opioid-Use Disorders in Pregnancy: Management Guidelines for Improving Outcomes (pp. 49-56). Cambridge: Cambridge University Press
• Klie K, Brooks L. Opioid Use in Pregnancy: High Risk and High Reward. Colorado Medicine. 2017 Sept/October; 114(5): 32-33.
• Hallucinogens in Pregnancy, book chapter in Compassionate Care for Pregnant People with Substance use, book in process.
• Location of Care for Patients with Borderline Personality Disorder: Challenges and Opportunities in Finding a Home
• "Medical Comorbidities in Women with Opioid Use Disorder in Pregnancy" for a book entitled Opioid Use Disorders in Pregnancy, currently in press.

Professional Memberships

• Colorado Society of Addiction Medicine (COSAM), Member
• American Society of Addiction Medicine (ASAM), Member
• American Academy of Family Physicians (AAFP), Member
• Alpha Omega Alpha Honor Medical Society, Member

Practice Locations

• University of Colorado Hospital
• Denver Health Medical Center

Specialty Information

• Family Medicine, Board Certification
• Addiction Medicine, Board Certification (0001)

• Substance Abuse
• Pregnancy and Reproduction - Prenatal Care
• Pregnancy and Reproduction
• Primary Care